iFirst Medical Technologies careers

iFirst provides point-of-care diagnostic solutions with laboratory-grade fidelity. Our diagnostic platform employs single-use disposable cartridges to save time; in critical care and trauma settings. The iFirst platform targets blood coagulation, the second most common diagnostic market. iFirst will quickly expand with additional critical care assays and establish itself as a platform in hospital operating rooms,emergency rooms and ambulances. The problem is the traditional VT systems are too large, complicated and expensive. iFirst’s handheld iVT8 provides a cost-effective VT solution, capable of global distribution. The iVT8 will be obtaining the CE Mark and launching EU sales this year.
GO TO MARKET
• $7 Billion Viscoelastic Test, Coagulation market, razor razorblade business model

WHAT WE DO
• Point-of-care diagnostics platform development
• Mobile health
• Cost effective Bio-MEMS development
• IVD Assay development

WHAT WE TARGET
• Saving lives with faster results
• Connecting wirelessly for improved efficiency
• Cost savings via improved outcomes

OUR TECHNOLOGY
• Low cost approach to complex lab tests
• Handheld platform, with broad healthcare applications
• Machine learning and computer driven apps

Link to Deck
docsend.com/view/9isqwi24x5ymbdmq